Sponsor Deadline
Posted: 2/25/2025

Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01, R21, R34 Clinical Trial Optional)

The NIMH invites applications for Research Project Grants (R01) that propose to advance innovative research to optimize HIV prevention, treatment, and care. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, large-scale intervention efficacy or effectiveness trials, implementation science studies, or data science approaches to optimize HIV prevention, treatment, and care. Applicants are encouraged to read current Notice of Special Interest (NOSIs) from NIMH Division of AIDS Research (DAR) for further information about the Division’s research priorities (NIMH DAR; https://www.nimh.nih.gov/about/organization/dar/aids-related-funding-opportunity-announcements-foas), and the NIH Strategic Plan for HIV and HIV-Related Research by NIH Office of AIDS Research (NIH OAR; https://www.oar.nih.gov/hiv-policy-and-research/strategic-plan).

This FOA, PAR-23-062, uses the R01 grant mechanism for applications with preliminary data or those including longitudinal analysis, advanced modeling, large-scale clinical trials or implementation science studies. Applicants proposing to conduct exploratory, novel studies that break new ground, extend previous discoveries in new directions or result in novel techniques, models or applications should consider the R21 mechanism (PAR-23-061). Applicants proposing the initial development and pilot testing of a clinical trial or formative implementation research should consider using the R34 mechanism (PAR-23-060).

Deadlines:

  • AIDS Application Due Dates: May 9, 2023; Sep 8, 2023; Jan 9, 2024; May 9, 2024; Sep 10, 2024; Jan 9, 2025; May 9, 2025; Sep 9, 2025; Jan 9, 2026


PAR-23-062 Expiration Date January 10, 2026